Clinical trial
Project Affinity: Excess Cancer Blood Testing Technique
NCT04724005 is registered in ClinicalTrials.gov with Entia Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Project Affinity: Excess Cancer Blood Testing Technique
- Lead sponsor
- Entia Ltd
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 15, 2021
- Completion date
- August 31, 2022
- Enrollment
- 613 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer